Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Toll-like receptor-targeted anti-tumor therapies: Advances and challenges. | Front Immunol | 2022 | 36479129 | PubTator, text mining | PubMed |
| Recent miRNA Research in Asthma. | Curr Allergy Asthma Rep | 2022 | 36459329 | PubTator, text mining | PubMed |
| Comparative immune-relevant transcriptome reveals the evolutionary basis of complex traits. | iScience | 2022 | 36458261 | PubTator, text mining | PubMed |
| Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs. | Nat Immunol | 2022 | 36456734 | PubTator, text mining | PubMed |
| Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses. | RMD Open | 2022 | 36456101 | PubTator, text mining | PubMed |
| Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy. | Theranostics | 2022 | 36451865 | PubTator, text mining | PubMed |
| Transcriptomic profiling implicates PAF1 in both active and repressive immune regulatory networks. | BMC Genomics | 2022 | 36451099 | PubTator, text mining | PubMed |
| The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement. | Front Neurol | 2022 | 36438941 | PubTator, text mining | PubMed |
| Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma. | EBioMedicine | 2022 | 36434949 | PubTator, text mining | PubMed |
| Lupus, DNA Methylation, and Air Pollution: A Malicious Triad. | Int J Environ Res Public Health | 2022 | 36429769 | PubTator, text mining | PubMed |
| Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy. | Cancers (Basel) | 2022 | 36428666 | PubTator, text mining | PubMed |
| Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer. | Front Oncol | 2022 | 36425563 | PubTator, text mining | PubMed |
| Immune modulating nanoparticles for the treatment of ocular diseases. | J Nanobiotechnology | 2022 | 36424630 | PubTator, text mining | PubMed |
| STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma. | BMC Cancer | 2022 | 36424540 | PubTator, text mining | PubMed |
| Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment. | Arch Pharm Res | 2022 | 36422795 | PubTator, text mining | PubMed |
| The Role of Dendritic Cells in the Host Response to Marek's Disease Virus (MDV) as Shown by Transcriptomic Analysis of Susceptible and Resistant Birds. | Pathogens | 2022 | 36422592 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Effects of sterilization methods on gelatin methacryloyl hydrogel properties and macrophage gene expressionin vitro. | Biomed Mater | 2022 | 36410038 | PubTator, text mining | PubMed |
| Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction. | Front Oncol | 2022 | 36408130 | PubTator, text mining | PubMed |
| The Relationship Between Sjogren's Syndrome and Sleep Disturbance: A Case Report. | Cureus | 2022 | 36407133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=36